606
Views
0
CrossRef citations to date
0
Altmetric
Commentary

Tumor responsiveness to statins requires overexpression of the ARF6 pathway

, , &
Article: e1185564 | Received 28 Apr 2016, Accepted 28 Apr 2016, Published online: 30 Jun 2016

References

  • Endo A, Kuroda M, Tsujita Y. ML-236A, ML-236B, and ML-236C, new inhibitors of cholesterogenesis produced by Penicillium citrinium. J Antibiot 1976; 29:1346-1348; PMID:1010803; http://dx.doi.org/10.7164/antibiotics.29.1346
  • Goldstein JL, Brown MS. 1990. Regulation of the mevalonate pathway. Nature 1990; 343:425-430; PMID:1967820; http://dx.doi.org/10.1038/343425a0
  • Nielsen SF, Nordestgaard BG, Bojesen SE. Statin use and reduced cancer-related mortality. N Engl J Med 2012; 367:1792-1802; PMID:23134381; http://dx.doi.org/10.1056/NEJMoa1201735
  • Hashimoto A, Oikawa T, Hashimoto S, Sugino H, Yoshikawa A, Otsuka Y, Handa H, Onodera Y, Nam JM, Oneyama C, et al. P53- and mevalonate pathway-driven malignancies require Arf6 for metastasis and drug resistance. J Cell Biol 2016; 213:81-95; PMID:27044891; http://dx.doi.org/10.1083/jcb.201510002
  • Sabe H. Requirement for Arf6 in cell adhesion, migration, and cancer cell invasion. J Biochem 2003; 134:485-489; PMID:14607973; http://dx.doi.org/10.1093/jb/mvg181
  • Sabe H, Hashimoto S, Morishige M, Ogawa E, Hashimoto A, Nam JM, Miura K, Yano H, Onodera Y. The EGFR-GEP100-Arf6-AMAP1 signaling pathway specific to breast cancer invasion and metastasis. Traffic 2009; 10: 982-993; PMID:19416474; http://dx.doi.org/10.1111/j.1600-0854.2009.00917.x
  • Hashimoto S, Mikami S, Sugino H, Yoshikawa A, Hashimoto A, Onodera Y, Furukawa S, Handa H, Oikawa T, Okada Y, et al. Lysophosphatidic acid activates Arf6 to promote the mesenchymal malignancy of renal cancer. Nat Commun 2016; 7:10656; PMID:26854204; http://dx.doi.org/10.1038/ncomms10656
  • Morishige M, Hashimoto S, Ogawa E, Toda Y, Kotani H, Hirose M, Wei S, Hashimoto A, Yamada A, Yano H, et al. GEP100 links EGFR signaling to Arf6 activation to induce breast cancer invasion. Nat Cell Biol. 2008; 10:85-92; PMID:18084281; http://dx.doi.org/10.1038/ncb1672
  • Kinoshita R, Nam JM, Ito YM, Hatanaka KC, Hashimoto A, Handa H, Otsuka Y, Hashimoto S, Onodera Y, Hosoda M, et al. Co-overexpression of GEP100 and AMAP1 proteins correlates with rapid local recurrence after breast conservative therapy. PLoS ONE 2013; 8:e76791; PMID:24116160; http://dx.doi.org/10.1371/journal.pone.0076791
  • Ahern TP, Lash TL, Damkier P, Christiansen PM, Cronin-Fenton DP. Statins and breast cancer prognosis: evidence and opportunities. Lancet Oncol 2014; 15:e461-8; PMID:25186049; http://dx.doi.org/10.1016/S1470-2045(14)70119-6

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.